Skip to main content
. Author manuscript; available in PMC: 2012 Mar 1.
Published in final edited form as: Cancer Res. 2010 Nov 2;70(22):9253–9264. doi: 10.1158/0008-5472.CAN-10-1447

Figure 1. Prognostic value of βIII-tubulin expression in predicting the biochemical recurrence after radical prostatectomy in HNPC prostate cancer patients.

Figure 1

A, B, C. Representative staining for βIII-tubulin in HNPC TMAs: absence of staining (A), moderate staining (B), strong staining (C). Photomicrographs are taken at x20 objective magnification (A–C) and x10 objective magnification; insets (A–C). Scale Bar, 100μm.

D. Recurrence-free survival (RFS) curves stratified by the expression of βIII-tubulin (negativity versus positivity of immunostaining, log-rank test; p=0.002). HNPC: hormone naive prostate cancer; TMA: tissue micro-array.